Can global leaders agree on a tough AMR plan? – POLITICO
Another key target is promoting innovation and access. The pipeline of novel antibiotics is severely limited and existing therapies are difficult to access, especially in lower- and middle- income countries — which are already bearing a heavier burden of antimicrobial resistant infections. Anand Anandkumar, co-founder and CEO of Indian pharmaceutical company Bugworks, said he believes the … Read more
